The US consumer health products industry could be looking ahead and seeing an improving outlook for growth since the Food and Drug Administration published a long-awaited proposal for facilitating additional OTC drug switches.
Manufacturers and marketers also likely are seeing a brighter marketplace on the horizon after a Perrigo Company PLC business submitted the first-ever proposal
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?